Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Are the Projected Market Size and Growth Rates for the Transcriptomics Market From 2025 To 2029?

The transcriptomics market has seen substantial growth in recent years. The market size is projected to increase from $6.51 billion in 2024 to $7.04 billion in 2025, recording a compound annual growth rate (CAGR) of 8.2%. The remarkable growth in the historic period is due to factors such as the growing emphasis on personalized medicine, an escalating prevalence of cancer, the acceptance of genomics in clinical diagnostics, the development of ribonucleic acid sequencing, and the heightened demand for biomarker discovery.

The market size of transcriptomics is predicted to witness significant expansion in the forthcoming years, escalating to$9.57 billion in 2029 with an 8.0% compound annual growth rate (CAGR). The substantial growth during the projection period is due to the increasing use of single-cell ribonucleic acid sequencing, the expanded role of spatial transcriptomics, the growing requirement for multiomics methods, amplified emphasis on early disease detection, and enhanced understanding of non-coding ribonucleic acid’s importance. The major trends to watch in the predicted period include improvements in next-generation sequencing (NGS) technologies, advancements in spatial transcriptomics techniques, further development of bioinformatics tools, incorporation of machine learning in transcriptomics, and progress in real-time transcriptomic analysis technology.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24417&type=smp

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Transcriptomics Market?

The growth of the transcriptomics market is set to be driven by the increasing acceptance of personalized medicine. This approach to medical treatment takes into account the unique genetic profile, lifestyle, and environmental factors of each individual. Growth in personalized medicine is fuelled by developments in genetic sequencing, which enable more effective treatments tailored to distinct genetic profiles. Transcriptomics reveals the unique patterns of gene expression in each individual, facilitating personalized treatments that coincide with the patient’s unique biological makeup. This method bolsters the effectiveness of therapies, reduces side effects, and aids early diagnosis of diseases. For instance, the Personalized Medicine Coalition noted that a US-based hospital and healthcare organization received FDA approval for 16 new personalized treatments for patients with rare diseases in 2023, a considerable increase from just six approvals in 2022. Therefore, it’s clear that the rise in acceptance of personalized medicine is a driving factor in the expansion of the transcriptomics market.

Which Key Market Segments Comprise the Transcriptomics Market and Drive Its Revenue Growth?

The transcriptomicsmarket covered in this report is segmented –

1) By Type: Instruments; Consumables; Software; Services

2) By Technology: Micro Array; Real-Time Quantitative Polymerase Chain Reaction; Sequencing Technologies

3) By Application: Diagnostics And Disease Profiling; Drug Discovery; Other Applications

4) By End-User: Academic And Research Institutes; Pharmaceutical Companies; Biotechnology Companies; Other End-Users

Subsegments:

1) By Instruments: Microarray Instruments; Sequencing Instruments; Polymerase Chain Reaction (PCR) Instruments; Other Transcriptomics Instruments

2) By Consumables: Reagents; Probes; Kits; Chips

3) By Software: Data Analysis Software: Data Management Software; Visualization Software: Bioinformatics Software

4) By Services: Data Analysis Services; Sample Preparation Services; Sequencing Services; Consulting Services

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24417&type=smp

Which Areas Are Leading Regions in the Transcriptomics Market Expansion Across the Globe?

North America was the largest region in the transcriptomics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transcriptomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Are the Key Market Trends in theTranscriptomics Market Over the Coming Years?

Leading firms in the transcriptomics market are concentrating on creating enhanced products like single-cell spatial panels to facilitate deeper understanding of cell functions and disease mechanisms. Single-cell spatial panels monitor gene expression at the individual cell level while sustaining the position of each cell within the tissue. This combination of spatial data with single-cell transcriptomics provides insights into both the activity of cells and the structure of tissues. For example, in February 2024, the US-based biotech firm, NanoString Technologies, introduced the CosMx 6,000 plex RNA Assay, a spatial molecular imaging assay. This introduction signifies the market’s first commercially available single-cell spatial panel capable of measuring over 6,000 RNA targets across nearly all human biological pathways. This advancement, meant for use with the CosMx Spatial Molecular Imager (SMI), empowers researchers to profile genes at single-cell and subcellular resolution with high precision and advanced cell segmentation.

View the full report here:

https://www.thebusinessresearchcompany.com/report/transcriptomics-global-market-report

How Is the Transcriptomics Market Conceptually Defined?

Transcriptomics is the study of all ribonucleic acid (RNA) transcripts produced by the genome in a specific cell, tissue, or condition. It helps decode gene expression patterns and regulatory mechanisms, revealing how these change in response to diseases or environmental factors. This field offers deep insights into cellular functions and disease pathways. Transcriptomics is crucial for biomarker discovery, therapeutic target identification, and advancing personalized medicine.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24417

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model